June 29, 2025
avatar-torie-bosch
First Opinion editor

This week, First Opinion had newsy op-eds from big names: five former chairs of the CDC’s Advisory Committee on Immunization Practice, 110 biotech CEOs and board chairs, the CEO of PhRMA.

But I wanted to highlight a piece that was not so on top of the news cycle. It’s an essay that offers some nuance to the discourse about teenagers’ mental health and screen time. Perhaps, adolescent and child psychiatrist Paul Weigle argues, the problem isn’t just that screens themselves hurt mental health — it’s also that screen time disrupts sleep. “Sleep deprivation impairs learning considerably, strongly predicting declining grades,” he writes. “It also predisposes youth to depression, anxiety, suicidality, and obesity. Multiple studies confirm that the relationship between screen time and poor mental health is related to its negative effect on sleep.”

It’s the kind of narrative-complicating idea that I love to publish.

Recommendation of the week: This week, the “Liver King” — Brian Johnson, an influencer who became famous for promoting an “ancestral” way of life — was arrested for threatening podcaster Joe Rogan. I recently watched and enjoyed Netflix’ documentary about Johnson’s rise to social media fame — and his scandalous downfall. It’s a fascinating look at the intersection of wellness and notoriety.



Adobe

Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress

Damaging reductions in research funding provided to academic and federal scientists will immediately hurt the biotechnology sector

By 110 Biopharma Leaders


Creating a better system to assess presidential physical and psychological health

The American public deserves a transparent health report of a sitting president from an independent, non-political, peer-selected, medical organization.

By M. Sara Rosenthal


We will not stay silent on vaccines, say leaders of five major U.S. medical associations

Presidents of the AAFP, AAP, ACP, ACOG, and IDSA write about their organizations’ commitment to vaccines in a time when immunizations are at risk.

By Jen Brull, Susan J. Kressly, Jason Goldman, Steven J. Fleischman, and Tina Q. Tan


Anna Moneymaker/Getty Images

Private sector, philanthropy can’t replace Trump administration science cuts

Some have proposed philanthropy or the private sector could make up for NIH funding cuts. But they can’t come close.

By James Alwine and Gregg Gonsalves


Will Congress’ Medicaid reforms really kill people?

A serious charge deserves solid evidence, and the tie between insurance coverage and overall health is surprisingly weak, expert says in STAT First Opinion.

By Liam Sigaud


STAT+ | PhRMA CEO: ‘Most-favored nation’ policy isn’t the way to lower drug prices

Instead of implementing foreign price controls, the U.S. should tackle 340B and PBM reforms, plus global freeloading.

By Stephen J. Ubl


Activists attend a rally for transgender youth on June 18 in Washington, D.C., after the U.S. Supreme Court upheld a state ban on gender-affirming medical care. Similar bans have spread rapidly across the country.
Anna Moneymaker/Getty Images

What the Supreme Court doesn’t understand about medical care for trans youth

“Only the patient’s identity determines whether I am practicing medicine or committing a crime,” an adolescent medicine specialist writes.

By Candice Mazon


Maybe the teen mental health crisis is actually a sleep crisis

Excessive screen time by teens harms sleep and fuels depression, anxiety, and obesity. Expert urges parents to focus on the sleep loss, not the screen time.

By Paul Weigle


A grim milestone: U.S. is on the cusp of losing its official measles elimination status

The fight against measles is threatened by a well-funded, emboldened antivaccine movement and the highest levels of federal public health agencies.

By Adam Ratner


Ted S. Warren/AP

‘Too many, too soon’? Debunking a common fear about kids’ vaccines

Today's entire vaccine schedule exposes a child to about 165 antigens. A single ’80s pertussis shot had more than 3,200.

By Jake Scott


STAT+ | The Senate’s version of Trump’s tax-cut bill threatens safety-net hospitals like ours

While the House One Big Beautiful Bill preserves vital existing Medicaid financing, the Senate bill would have the opposite effect.

By Esmaeil Porsa and Christine Alexander


STAT+ | Health care costs: one of the biggest obstacles to reshoring American industry

Health care costs have played a major role in American companies deciding to move jobs offshore.

By Kevin A. Schulman and Wasan Kumar


Nardus Engelbrecht

STAT+ | The decades-long journey to Gilead’s twice-a-year HIV prevention drug lenacapavir

“It looks like an alien molecule”: How scientists created Gilead’s new HIV prevention drug lencapavir, or Yeztugo.

By William Pao


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.